BACKGROUND: The goal of this study is to determine the presence of platelet dysfunction in patients with traumatic brain injury (TBI). The mechanisms underlying the coagulopathy associated with TBI remain elusive. The question of platelet dysfunction in TBI is unclear. METHODS: This was a prospective observational study conducted at Memorial Hospital of South Bend, IN, and Denver Health Medical Center, CO. A total of 50 patients sustaining TBI, and not under treatment with anticoagulants or platelet inhibitors, were analyzed utilizing modified thromboelastography (TEG) with platelet mapping (TEG/PM), along with standard coagulation tests. RESULTS: Compared to normal controls, patients with severe TBI had a significantly increased percentage of platelet ADP and arachidonic acid (AA) receptor inhibition. Furthermore, the percentage of ADP inhibition distinguished between survivors and non-survivors in patients with TBI (Mann-Whitney test, P = 0.035). ADP inhibition correlates strongly with severity of TBI (Mann-Whitney test, P = 0.014), while AA inhibition did not. CONCLUSION: These data indicate that early platelet dysfunction is prevalent after severe TBI, can be measured in a point-of-care setting using TEG/PM, and correlates with mortality. The mechanism responsible for this platelet dysfunction and associated implications for TBI management remains to be defined.
BACKGROUND: The goal of this study is to determine the presence of platelet dysfunction in patients with traumatic brain injury (TBI). The mechanisms underlying the coagulopathy associated with TBI remain elusive. The question of platelet dysfunction in TBI is unclear. METHODS: This was a prospective observational study conducted at Memorial Hospital of South Bend, IN, and Denver Health Medical Center, CO. A total of 50 patients sustaining TBI, and not under treatment with anticoagulants or platelet inhibitors, were analyzed utilizing modified thromboelastography (TEG) with platelet mapping (TEG/PM), along with standard coagulation tests. RESULTS: Compared to normal controls, patients with severe TBI had a significantly increased percentage of platelet ADP and arachidonic acid (AA) receptor inhibition. Furthermore, the percentage of ADP inhibition distinguished between survivors and non-survivors in patients with TBI (Mann-Whitney test, P = 0.035). ADP inhibition correlates strongly with severity of TBI (Mann-Whitney test, P = 0.014), while AA inhibition did not. CONCLUSION: These data indicate that early platelet dysfunction is prevalent after severe TBI, can be measured in a point-of-care setting using TEG/PM, and correlates with mortality. The mechanism responsible for this platelet dysfunction and associated implications for TBI management remains to be defined.
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: John B Holcomb; Charles E Wade; Joel E Michalek; Gary B Chisholm; Lee Ann Zarzabal; Martin A Schreiber; Ernest A Gonzalez; Gregory J Pomper; Jeremy G Perkins; Phillip C Spinella; Kari L Williams; Myung S Park Journal: Ann Surg Date: 2008-09 Impact factor: 12.969
Authors: Roger C Carroll; Robert M Craft; Russell J Langdon; Colin R Clanton; Carolyn C Snider; Douglas D Wellons; Patrick A Dakin; Christy M Lawson; Blaine L Enderson; Stanley J Kurek Journal: Transl Res Date: 2009-05-03 Impact factor: 7.012
Authors: Emily F Midura; Peter L Jernigan; Joshua W Kuethe; Lou Ann Friend; Rosalie Veile; Amy T Makley; Charles C Caldwell; Michael D Goodman Journal: J Surg Res Date: 2015-03-05 Impact factor: 2.192
Authors: M J George; J Burchfield; B MacFarlane; Y-W W Wang; J C Cardenas; N J White; B S Gill; C E Wade Journal: Transfus Med Date: 2017-09-15 Impact factor: 2.019
Authors: Victoria A Ploplis; Deborah L Donahue; Mayra J Sandoval-Cooper; Maria MorenoCaffaro; Patrick Sheets; Scott G Thomas; Mark Walsh; Francis J Castellino Journal: J Neurotrauma Date: 2014-05-21 Impact factor: 5.269
Authors: Phillip V Parry; Phillip A Choi; Joshua S Bauer; David M Panczykowski; Ava M Puccio; David O Okonkwo Journal: Neurosurgery Date: 2017-01-01 Impact factor: 4.654
Authors: Deborah L Donahue; Julia Beck; Braxton Fritz; Patrick Davis; Mayra J Sandoval-Cooper; Scott G Thomas; Robert A Yount; Mark Walsh; Victoria A Ploplis; Francis J Castellino Journal: J Neurotrauma Date: 2013-11-21 Impact factor: 5.269
Authors: Hideki Yasui; Deborah L Donahue; Mark Walsh; Francis J Castellino; Victoria A Ploplis Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-05-17 Impact factor: 5.464
Authors: Francis J Castellino; Michael P Chapman; Deborah L Donahue; Scott Thomas; Ernest E Moore; Max V Wohlauer; Braxton Fritz; Robert Yount; Victoria Ploplis; Patrick Davis; Edward Evans; Mark Walsh Journal: J Trauma Acute Care Surg Date: 2014-05 Impact factor: 3.313